169 related articles for article (PubMed ID: 35599272)
1. The prophylactic and anti-fibrotic activity of phthalimido-thiazole derivatives in schistosomiasis mansoni.
Laranjeira Miranda Filho CA; de Oliveira Barbosa M; Rodrigues Oliveira A; Ferreira Pinto A; Araújo DL; Lucena JP; de Araújo RE; de Oliveira SA; Lima Leite AC
Parasitol Res; 2022 Jul; 121(7):2111-2120. PubMed ID: 35599272
[TBL] [Abstract][Full Text] [Related]
2. Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma mansoni.
de Oliveira SA; de Oliveira Barbosa M; Filho CALM; Oliveira AR; de Sousa FA; de Farias Santiago E; de Oliveira Filho GB; de Moraes Gomes PAT; da Conceição JM; Brayner FA; Alves LC; Leite ACL
Parasitol Res; 2018 Jul; 117(7):2105-2115. PubMed ID: 29736731
[TBL] [Abstract][Full Text] [Related]
3. Schistosomicidal and prophylactic activities of phthalimido-thiazoles derivatives on schistosomula and adult worms.
de Oliveira Barbosa M; de Oliveira SA; Filho CALM; Oliveira AR; Fernandes CJB; Lucena JP; de Sousa FA; de Barros Dias MCH; Brayner FA; Alves LC; Leite ACL
Eur J Pharm Sci; 2019 May; 133():15-27. PubMed ID: 30877068
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of multi-target phtalimido-thiazoles on Schistosomiasis mansoni.
Filho CALM; Barbosa MO; Oliveira AR; Santiago EF; de Souza VCA; Lucena JP; Fernandes CJB; Santos IRD; Leão RLC; Santos FABD; Alves LC; Pereira VRA; de Araújo RE; Leite ACL; de Oliveira SA
Eur J Pharm Sci; 2020 Apr; 146():105236. PubMed ID: 32058057
[TBL] [Abstract][Full Text] [Related]
5. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mode of action of 1,2,6,7-tetraoxaspiro [7.11] nonadecane (N-89) against adult Schistosoma mansoni worms.
Blay EA; Kumagai T; Yamabe M; Hino A; Shimogawara R; Kim HS; Sato A; Ichimura K; Ayi I; Iwanaga S; Ohta N
Parasitol Int; 2018 Aug; 67(4):403-412. PubMed ID: 29617630
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of aryl-thiazole derivatives against Schistosoma mansoni schistosomula and adult worms.
Pereira ASA; Silveira GO; Amaral MS; Almeida SMV; Oliveira JF; Lima MCA; Verjovski-Almeida S
PLoS One; 2019; 14(11):e0225425. PubMed ID: 31765429
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
9. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Eldeeb E; Fahmy S; Elbakry K; Hyder A
Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
[TBL] [Abstract][Full Text] [Related]
10. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
11. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Parasit Vectors; 2020 Sep; 13(1):474. PubMed ID: 32933556
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
13. The Existing Drug Nifuroxazide as an Antischistosomal Agent:
Roquini V; Mengarda AC; Cajas RA; Martins-da-Silva MF; Godoy-Silva J; Santos GA; Espírito-Santo MCC; Pavani TFA; Melo VA; Salvadori MC; Teixeira FS; Rando DGG; de Moraes J
Microbiol Spectr; 2023 Aug; 11(4):e0139323. PubMed ID: 37409934
[TBL] [Abstract][Full Text] [Related]
14. Immunological and parasitological parameters in Schistosoma mansoni-infected mice treated with crude extract from the leaves of Mentha x piperita L.
Dejani NN; Souza LC; Oliveira SR; Neris DM; Rodolpho JM; Correia RO; Rodrigues V; Sacramento LV; Faccioli LH; Afonso A; Anibal FF
Immunobiology; 2014 Aug; 219(8):627-32. PubMed ID: 24767421
[TBL] [Abstract][Full Text] [Related]
15. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
Allam G; Eweas AF; Abuelsaad AS
Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
[TBL] [Abstract][Full Text] [Related]
17. Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus.
Ernould JC; Ba K; Sellin B
Acta Trop; 1999 Jul; 73(2):143-52. PubMed ID: 10465054
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
19. Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.
Pereira VRD; da Silveira LS; Mengarda AC; Alves Júnior IJ; da Silva OOZ; Miguel FB; Silva MP; Almeida ADC; Torres DDS; Pinto PF; Coimbra ES; de Moraes J; Couri MRC; da Silva Filho AA
Acta Trop; 2021 Jan; 213():105741. PubMed ID: 33159900
[TBL] [Abstract][Full Text] [Related]
20. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
